Sable Therapeutics
Biotech meets beauty.
New York, United States · Founded 2020
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2C
- Website
- sabletherapeutics.com
About
Sable Therapeutics operates at the intersection of biotechnology and beauty, developing clinically grounded beauty brands built on breakthrough science. The company holds an exclusive worldwide license from Columbia University to develop novel polycation nanomedicines — including SBL-001 and SBL-002 — designed to selectively reduce fat cell volume as topical treatments for obesity. Sable applies a pharmaceutical development methodology to consumer beauty, creating differentiated products backed by peer-reviewed scientific discovery.
Summary
Sable Therapeutics is a Biotech company based in New York, United States, founded in 2020.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...